BELLEZZA, Guido
 Distribuzione geografica
Continente #
NA - Nord America 4.731
EU - Europa 3.802
AS - Asia 1.344
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
SA - Sud America 5
Totale 9.910
Nazione #
US - Stati Uniti d'America 4.679
IT - Italia 889
IE - Irlanda 822
UA - Ucraina 705
SG - Singapore 481
SE - Svezia 419
HK - Hong Kong 392
CN - Cina 203
FI - Finlandia 189
DE - Germania 180
RU - Federazione Russa 156
VN - Vietnam 156
GB - Regno Unito 108
FR - Francia 82
RO - Romania 82
KR - Corea 61
CA - Canada 47
BE - Belgio 35
CH - Svizzera 23
PL - Polonia 22
TR - Turchia 17
AT - Austria 16
NL - Olanda 14
PT - Portogallo 14
GR - Grecia 11
LB - Libano 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 9
EG - Egitto 9
ES - Italia 7
AU - Australia 6
EU - Europa 6
MX - Messico 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BR - Brasile 3
IL - Israele 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
NO - Norvegia 2
TH - Thailandia 2
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
HU - Ungheria 1
JO - Giordania 1
JP - Giappone 1
LK - Sri Lanka 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TW - Taiwan 1
Totale 9.910
Città #
Chandler 1.003
Dublin 821
Hong Kong 392
Jacksonville 386
Singapore 374
San Mateo 367
Boardman 329
Santa Clara 221
Perugia 216
Ann Arbor 189
Medford 184
Princeton 183
Altamura 159
Dong Ket 156
Wilmington 147
Lawrence 120
Andover 107
Ashburn 98
Beijing 82
Bucharest 79
Seoul 61
Saint Petersburg 53
Ottawa 45
Woodbridge 40
Des Moines 39
Helsinki 38
Rome 37
Redmond 36
Brussels 34
Norwalk 34
Shanghai 34
San Paolo di Civitate 30
Los Angeles 25
Munich 24
New York 24
Redwood City 23
Houston 20
Milan 20
Auburn Hills 19
Izmir 17
Philadelphia 17
Kraków 16
Moscow 16
Falls Church 11
Dallas 9
Den Haag 9
Florence 9
West Jordan 8
Palermo 7
Simi Valley 7
Bologna 6
Marinha Grande 6
Nürnberg 6
Edinburgh 5
Fremont 5
Lappeenranta 5
Lausanne 5
Abidjan 4
Arezzo 4
Catania 4
Lisbon 4
Perth 4
Tappahannock 4
Terni 4
Zagazig 4
Amsterdam 3
Avellino 3
Bratislava 3
Castellarano 3
Chicago 3
Como 3
Frankfurt Am Main 3
Frankfurt am Main 3
Kiev 3
London 3
Marano Di Napoli 3
Montalto delle Marche 3
Montesilvano Marina 3
Paris 3
Phoenix 3
Serra 3
Terrassa 3
Trieste 3
Al Mansurah 2
Bari 2
Bergamo 2
Brno 2
Cairo 2
Castel Bolognese 2
Chieti 2
Costa Mesa 2
Dearborn 2
Faenza 2
Fairfield 2
Genova 2
Kansas City 2
Lanciano 2
Messina 2
Monmouth Junction 2
Nanjing 2
Totale 6.533
Nome #
Angiosarcoma primitivo del surrene 193
Granuloma piogenico: revisione della letteratura e presentazione di un caso 160
Condromatosi sinoviale primitiva dei tessuti molli. 146
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 145
Espressione della sialoproteina ossea, dell’osteopontina e dell’osteonectina nel carcinoma prostatico 141
Primary mucinous carcinoma of the skin 103
Nuovi metodi di rilevazione delle micrometastasi linfonodali. XXIII Congresso Nazionale di Chirurgia Oncologica 102
Aspirato con ago sottile dei noduli tiroidei: striscio convenzionale vs preparato in strato sottile. 101
Significato prognostico dell’espressione immunoistochimica di Insulin like growth facor receptor 1 (IGFR-1) ed epidermal growth factor receptor (EGFR) nei carcinomi non a piccole cellule del polmone (NSCLC). 101
Valutazione anatomo-patologica dell’unità feto-placentare nella morte prenatale. 100
The correlation of protein peroxidation with morphological changes in experimental oestradiol-induced carcinogenesis 99
p53 overexpression predicts the resistance to chemotherapy in advanced non small cell lung cancer (NSCLC)". 93
Prognostic Role of Erbb Family Receptors, Myc and Mitogen-activated Protein Kinase (mapk) In Patients With Early-stage Non Small-cell Lung Cancer 93
Immunohistochemical expression of IMP3 in non small cell lung cancer. 91
Nested Type Bladder Cancer: A Tricky Entity A Report of Two Cases 91
Leiomyoma of the breast: case report and review of the literature. 90
Ossificazione eterotopica e patologia tiroidea: descrizione di 6 casi e revisione della letteratura 89
Ruolo dei marcatori biologici negli stadi iniziali dei NSCLC tattati con resezione chirurgica radicale. Congresso Nazionale SICO 86
Biological Prognostic Factors for early stage completely resected NSCLC 82
Appendiceal mucocele. A case report and literature review 82
P-126 * PROGNOSTIC SIGNIFICANCE OF MYC AND HUMAN TELOMERASE GENE AMPLIFICATION IN SURGICALLY TREATED EARLY STAGE NON-SMALL CELL LUNG CANCER 82
Predictors of resistance to chemotherapy and prognosis in advanced non-small cell lung cancer. 80
Espressione di EGFR e timidilato sintetasi nel carcinoma rettale: correlazioni anatomo-cliniche e significato prognostico - IV Congresso Nazionale di Anatomia Patologica 80
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer 80
Espressione di MKP-1 nei noduli iperplastici, adenomi e carcinomi papillari della tiroide. 78
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non small cell lung cancer (NSCLC) 77
Apocrine intraductal carcinomas arising in two fibroadenomas: report of an unusual case. 77
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis 77
6th National Conress of Medical Oncology 74
Coexpression of HER-2/neu and p53 in breast cancer identifies a subset with an aggressive biopathological profile. 74
Fine needle aspiration cytology of thyroid nodules: conventional smears vs thin layer technique 73
CD10 is frequently expressed in classical seminomas. 72
ATTIVAZIONE IN SITU DELLE METALLOPROTEINASI DA PARTE DEL SISTEMA FIBRINOLITICO COME MECCANISMO PATOGENETICO DELLA ROTTURA DELLA PLACCA ATEROSCLEROTICA. 71
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free servival in resected non-small-cell lung cancer patients. 70
Future options for ALK-positive non-small cell lung cancer 69
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 69
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 68
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer 67
An additional case of breast tumor resembling the tall cell variant of papillary thyroid carcinoma. 67
1° Simposio Nazionale di Citopatologia "Dallo screening alla citologia diagnostica" 66
Espressione delle citocheratine basali nei carcinomi mammari pT1b: studio clinico patologico. 65
Confronto tra citologia aspirativa con ago sottile e parametri eco-color-doppler nei noduli tiroidei 64
Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERα 64
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. 63
Dyskerin and TERC expression may condition survival in lung cancer patients 62
Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib 61
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor 61
SIGNIFICATO PROGNOSTICO DI ALCUNI PARAMETRI BIOPATOLOGICI IN 99 CASI DI CARCINOMA DEL POLMONE NON-MICROCITOMA STADIO I-II. Atti congresso congiunto: Società italiana Anatomia Patologica e Citologia Diagnostica (SIAPEC) e International Academy of Pathology (IAP). Pathologica Vol 91 60
Tumori a cellule granulari (TCG): nuovi marcatori imunoistochimici. 60
Carcinoma della mammella pT1a: studio clinico-patologico 60
Tumore stromale gastrointestinale (GIST) in diverticolo di Meckel: descrizione di due casi 60
HER family receptors expression in squamous cell carcinoma of the tongue: study of the possible prognostic and biologic significance 60
Comparison between fine needle aspiration cytology and ultrasound features in thyroid nodules: an US score to select thyroid nodules requiring FNA. 60
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors. 60
Glyoxalase 2 drives tumorigenesis in human prostate cells in a mechanism involving androgen receptor and p53-p21 axis. 60
Modificazioni del profilo biopatologico del carcinoma della mammella: un ulteriore effetto dello screening mammografico? 59
Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hibridization. 59
Breast cancer in young women: clinicopathological features and biological specificity. 59
Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients. 59
Classification Model to Estimate MIB-1 (Ki 67) Proliferation Index in NSCLC Patients Evaluated With 18F-FDG-PET/CT 59
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition 58
Could thymomectomy be a reasonable option for non-myasthenic thymoma patients? 58
Mitotic index matter: how to improve the assessment of mitosis in order to better classify G2 breast cancer and luminal A category 58
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: An experimental study 58
Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro. 57
Carcinomi mammari "triple negative": studio dei fattori prognostici e predittivi. 57
Espressione delle proteine osteogenetiche nel carcinoma prostatico: correlazioni anatomo-cliniche e significato prognostico 57
Endometriosis-associated skeletal muscle regeneration: a hitherto undescribed entity and a potential diagnostic pitfall. 57
Carcinomi mammari “triple negative”: studio dei fattori prognostici e predittivi 57
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC). 57
Biological prognostic factors for early stage completely resected non-small cell lung cancer. 57
Carcinoma della mammella pT1a: studio clinico-patologico 56
Immunohistochemical analisis of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in papillary thyroid carcinoma (PYC): a marker of lymph node metastasis. 56
Detection of HER-/neu (c-erbB-2). Overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization. 55
Attivazione in situ delle metalloproteinasi da parte del sistema fibrinolitico come meccanismo patogenetico della rottura della placca aterosclerotica. 54
Espressione dei recettori HER nei carcinomi non a piccole cellule del polmone 54
Targeting the KRAS variant for treatment of non-small cell lung cancer: Potential therapeutic applications 54
IMP3 protein expression in triple negative breast carcinoma. 53
The clinical relevance of Bcl-2, Rb, p53 overexpression in advanced non small cell lung cancer. 52
Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. 52
Pleurodesis with Thulium Cyber Laser versus talc poudrage: a comparative experimental study 52
Primary signet-ring cell carcinoma of the urinary tract 51
Lymphangiogenesis in cutaneous melanoma:prognostic significance and correlation with sentinel lymph node status. 51
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer 51
Observational analysis on inflammatory reaction to talc pleurodesis: Small and large animal model series review 51
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 51
Ercc1 Mrna Expression and Kras Mutation Status In Egfr Wild Type (wt) Advanced Non-small Cell Lung Cancer (nsclc) Patients 50
How might treatment of ALK-positive non-small cell lung cancer change in the near future? 50
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib 50
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients 50
Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer 50
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy 50
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 50
Low dentin matrix protein 1 expression correlates with skeletal metastases development and enhances cell migratory capacity in vitro. 49
Systems biology in personalized medicine in oncology: A case study in non-small cell lung cancer 49
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors 49
Clinical Outcome With Platinum-Based Chemotherapy in Patients With Advanced Nonsquamous EGFR Wild-Type Non-Small-Cell Lung Cancer Segregated According to KRAS Mutation Status. 49
Osimertinib 48
A population survival model for breast cancer. 47
MYC and Human Telomerase Gene (TERC) Copy Number Gain in Early-stage Non-small Cell Lung Cancer 47
Totale 6.986
Categoria #
all - tutte 43.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.083


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020649 0 0 0 0 101 20 111 39 146 110 35 87
2020/20211.554 14 103 68 122 447 101 136 21 165 53 132 192
2021/20221.583 37 287 30 91 30 22 20 463 48 91 182 282
2022/20232.968 219 540 37 275 257 291 12 136 1.066 9 101 25
2023/20241.229 82 117 56 15 10 28 317 48 140 42 181 193
2024/2025966 74 303 158 89 342 0 0 0 0 0 0 0
Totale 10.405